BIOBOT Surgical
BIOBOT Surgical develops and manufactures robotic systems for prostate biopsy and treatment. Their flagship product, the Mona Lisa system, provides urologists with robotic precision and enhanced visualization for percutaneous transperineal procedures, improving patient outcomes. The company has already deployed over 50 Mona Lisa robots globally, performing over 20,000 procedures.
Funding Round: Series B
Funding Amount: $18M
Date: 07-Mar-2024
Investors: Mr. Tony Tan, ZIG Ventures
Markets: Medtech, Robotics, Urology
HQ: Singapore, Singapore, Singapore
Founded: 2007
Website: https://www.biobotsurgical.com
LinkedIn: https://www.linkedin.com/company/biobot-surgical-pte-ltd
Twitter: https://twitter.com/biobotmonalisa
Facebook: https://www.facebook.com/biobotsurgical
Leave a Comment
Comments
No comments yet.